论文部分内容阅读
由魏克民教授研究小组的“浙江省蚕副产品在中医药领域综合利用”系列项目又获得突破性进展。去年12月28日他们的“蚕砂提取物研制中药二类新药生血宁”的成果鉴定已达到国内领先、国际先进水平,不仅在治疗贫血方面取得巨大的社会效益和经济效益,而且为我国丰富的蚕业资源的综合利用拓展了广阔的
The “Zhejiang Sericulture By-products in the Field of TCM Comprehensive Utilization” project was also made a breakthrough by Professor Wei Kemin’s research group. On December 28th last year, their results of the identification of the “new silkworm extract of traditional Chinese medicine, the second class of Chinese medicine Shengxu Ning” had reached the leading domestic and international advanced level. Not only has it achieved huge social and economic benefits in the treatment of anemia, but also The comprehensive utilization of the abundant resources of sericulture in our country has expanded broadly